DALE NOVAK: Open Payments
NPI 1467544072 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,166 in 90 payments from 13 companies in 2025. Trend: 2023 $2,050 · 2024 $3,572 · 2025 $3,166
Food & beverage: $2,907Travel & lodging: $259
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $617 |
| PFIZER INC. | 25 | $540 |
| Lilly USA, LLC | 9 | $474 |
| Saluda Medical Americas, Inc. | 3 | $434 |
| Averitas Pharma Inc. | 10 | $338 |
| Forte Bio-Pharma LLC | 7 | $146 |
| Abbott Laboratories | 1 | $144 |
| AstraZeneca Pharmaceuticals LP | 1 | $126 |
| Medtronic, Inc. | 1 | $115 |
| Impel Pharmaceuticals LLC | 6 | $106 |
Products named: Evoke, NURTEC ODT, KISUNLA, QUTENZA, QULIPTA, UBRELVY, PROLATE, PROCLAIM.
Industry payments across OH — which companies pay providers there.
